ReviewJournal of artificial organs : the official journal of the Japanese Society for Artificial Organs2014
Current status of extracorporeal ventricular assist devices in Japan.
Review in Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 15 citations in OpenAlex.
- Impact of Different Therapeutic Strategies With Left Ventricular Assist Devices on Health-Related Quality of Life During Prolonged Device-Based Support.Circulation reports · 2023Article
- Preclinical animal study of the NIPRO-ventricular assist device for use in pediatric patients.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2018Article
- Novel temporary left ventricular assist system with hydrodynamically levitated bearing pump for bridge to decision: initial preclinical assessment in a goat model.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2018Article
- Successful bridge to recovery in fulminant myocarditis using a biventricular assist device: a case report.Journal of medical case reports · 2017Article
- Artificial hearts-recent progress: republication of the article published in the Japanese Journal of Artificial Organs.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2017Review
- Successful left ventricular assist device re-implantation with omental covering for MDRP device infection.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2016Article
- Nipro extra-corporeal left ventricular assist device fitting after left ventricular reconstruction with mitral valve plasty.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2015Article
- Early and mid-term outcomes of left ventricular assist device implantation and future prospects.General thoracic and cardiovascular surgery · 2015Article
- Seventeen-month-long paracorporeal biventricular mechanical support as a bridge to transplantation for severe dilated cardiomyopathy.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2015Article
- Development and current clinical application of ventricular assist devices in China.Journal of Zhejiang University. Science. BReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Extracorporeal VADs are less expensive, their prices reimbursable by the health insurance being about one-sixth of those of implantable VADs in Japan. However, a disadvantage is that, in Japan, their use is restricted to hospitals, necessitating prolonged hospitalization, reducing the patients' quality of life. According to the Japanese registry for Mechanically Assisted Circulatory Support, the survival rate does not differ significantly between patients with extracorporeal and implantable VADs. As in Europe and North America, extracorporeal VADs in Japan are commonly used as Bridge to Decision or Bridge to Recovery. Extracorporeal VADs are switched to implantable VADs as a Bridge-to-Bridge strategy after stabilization or when cardiac function recovery fails. They are also used as right ventricular assist devices (RVADs) in patients with right heart failure. A special characteristic of extracorporeal VADs in Japan is their frequent use as a Bridge to Candidacy. In Japan, indications for implantable VADs are restricted to patients registered for heart transplantation. Therefore, in patients who cannot be registered for transplantation because of transient renal dysfunction, etc., due to heart failure, extracorporeal VADs are used first, and then replaced by implantable VADs after transplant registry is done. Here, we describe the current status of extracorporeal VADs in Japan, focusing on the environmental backgrounds, along with a review of the relevant literature.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.